abstract |
The present invention relates to novel 2‐[thiophen‐2‐yl)formamido]‐N‐(phenyl)‐2‐methylpropanamides of general formulan A ,n processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions in which inhibition of the indoleamine 2,3-dioxygenase 1 (IDO1) enzyme may be beneficial. |